Long-term outcomes of drug-eluting stents versus bare metal stents in saphenous vein graft interventions. Evidence from a meta-analysis of randomized controlled trials
Highlights
- • DES results in similar outcomes as BMS in SVG PCI up to 42 months of mean follow up.
- • SVG PCI results in excess of 32% major adverse cardiovascular outcomes at 42 months.
- • Post CABG patients who undergo SVG PCI have a mortality rate of 15% at 42 months.
Abstract
Background
The optimal stent for use in saphenous vein graft (SVG) intervention is still debatable. Multiple randomized trials have compared drug-eluting stents (DES) to bare metal stents (BMS) in SVG interventions with conflicting results.